Press Release

INDO BORAX & CHEMICALS LTD. Regd. Office: 506, 5th Floor, Tulsiani Chambers, Free Press Journal Marg, Nariman Point, Mumbai - 400021. India. Ph.: 022 35218591 • CIN: L.24100MH1980PLC023177 Email : info(!t indoborax.com • Website : www.indoborax.com Date: August 10, 2026 To, To, BSE Limited, National Stock Exchange of India Ltd, Corporate Relationship Department, Listing Department, Phiroze Jeejeebhoy Towers, Exchange Plaza, Dalal Street, Fort, Bandra-Kurla Complex, Mumbai - 400 001 Bandra (East), Mumbai- 400 051 Stock Code: 524342 Stock Code: INDOBORAX Dear Sir / Ma' am, Subject: Press Release - Un-Audited Financial Results for the quarter ended June 30, 2026. Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the Press Release on the Un-Audited Financial Results for the quarter ended June 30, 2026. We request you to kindly take the same on record. Thanking you. For Indo Borax & Chemicals Limited Pravin Chavan Company Secretary & Compliance Officer Membership No.: A16857 . Encl: As above lndo Borax & Chemicals Ltd. lndo Borax reports a 59% surge in net profit at Rs 16.25 crore in Q1FV27, riding on higher demand and improved capacity utilisation • Operating Income grows by 31.34% at Rs 70.36 crore • Received Board approval for amalgamation of its wholly owned subsidiary lndoborax Infrastructure Private Ltd with lndo Borax Chemicals, subject to necessary regulatory approvals Mumbai, August 10, 2026: lndo Borax and Chemicals Ltd (BSE: 524342; NSE: INDOBORAX), one of the leading manufacturers of boron-based chemicals in India, posted a 59.31 per cent surge in net profit on a consolidated basis at Rs 16.25 crore for the quarter ended June 30, 2026, as against Rs 10.20 crore same period last year on the back of a strong demand and improved operational efficiencies. Consolidated Financial Highlights (In Rs. Crore) Particulars Qt FY27 Q1 FY26 Growth(%) Q4FY26 Growth(%) FY26 Operating Income 70.36 53.57 31.34 63.01 11.66 215.45 EBITDA 19.80 12.21 62.16 12.82 54.45 44.16 EBITDA Margin(%) 28.1 22.8 20.4 I 20.5 PAT 16.25 10.20 59.31 14.53 11.84 50.27 PAT Margin(%) 22.3 18.0 21.5 21.8 EPS (Rs.) 5.07 3.18 59.43 4.53 11.92 15.67 Operating income on a consolidated basis increased by 31.34 per cent to Rs 70.36 crore during the quarter under review, as compared with Rs 53.57 crore during the same period last year. EBITDA for the quarter was up at Rs 19.80 crore as compared with Rs 12.21 crore last year. Q1FY27 also witnessed robust growth in margins at EBITDA and PAT levels. The company's EBITDA margin increased by 530 basis points to 28.1%, and PAT margin increased by 430 basis points to 22.3% against Q1FY26. Commenting on the company's performance during the quarter, Mr. Suresh Katra, Managing Director & CEO, lndo Borax, said, "The boron-based chemicals market in India has been witnessing a robust demand across a diverse range of applications including steel, glass, ceramics, agriculture, electronics and detergents among others. With our advanced manufacturing capabilities, we are well-positioned to meet demand. Our capacity utilisation has been extremely robust, and improved operational efficiency has strengthened our bottom line. We expect to sustain this growth momentum moving forward." The company has received approval from its Board for the amalgamation of its wholly owned subsidiary, lndoborax Infrastructure Private Ltd, with lndo Borax Chemicals. This will be subject to necessary approvals from NCLT and other regulatory authorities. "The proposed amalgamation will help create greater efficiency due to pooling and more effective utilisation of the combined resources and will also create concentrated management focus besides streamlining governance and facilitating faster decision making," Mr. Katra said. lndo Borax & Chemicals Ltd. About lndo Borax & Chemicals Ltd. lndo Borax & Chemicals Ltd., established in 1980, is India's leading manufacturer of boron-based chemicals and the industry benchmark for Boric Acid. Being the only company to hold a Food and Drug Administration (FDA) license for manufacturing Pharma Grade Boric Acid as per the Indian Pharmacopoeia, moo Borax operates the most modern Boric Acid, Disodium Octaborate Tetra hydrate (D.O.T.), and Borax plant In Pithampur, Madhya Pradesh. It was also the first company in India to receive a BIS license for manufacturing Technical Grade Boric Acid. Backed by over 28,000 shareholders, lndo Borax was featured in Forbes Asia Pacific's Top 200 Under A Billion Dollar Public Companies (2023) and recognised by The Economic Times for its value-driven growth approach. For Media Queries Deepali Shah 9029557708 deepali@tollunapc.com For IR Queries Rajshree Ganguly 9833807235 raisbree@fortun~